Gadavist® (gadobutrol) injection 1mmol/mL
With You Along the Way
Connect with Your Bayer Representative Today to Find Out More on How Bayer Can Be a Partner for You
Powered by Experience
Behind Every Dose of Gadavist is Bayer
Over 44 million vials sold since US launch*
Experience in more than 2,800 institutions across the U.S.†
Evidence in numerous published studies worldwide‡
FDA-approved multi-patient presentation for use in the MR suite§
*Bayer Sales Data based on number of vials sold 03/2011 through 02/2026.
†Bayer Sales Data based on active institution accounts through 2026.
‡Literature Review. Embase database, gadobutrol, 1994-03/2026.
§When used with the FDA-cleared Transfer Spike.
Gadavist (gadobutrol) Is Part of the Bayer MR Portfolio of Solutions
Gadavist
- Backed by rigorous scientific data and our dedication to expanding the knowledge base for specialty MR procedures and patient populations since 2011
- Gadavist is used in 2,800+ institutions across the United States*, with over 44 million vials sold in the U.S. since launch†
MEDRAD® MRXperion MR Injection System
- Delivering efficiencies in contrast-enhanced studies with MEDRAD® MRXperion powered by connected software and services
- Over 10,200 Bayer MR power injectors are in use across the U.S.‡
Quality Syringes & Disposables
- Designed and manufactured in the U.S. and warranted as part of the total fluid-delivery system
- Backed by 50+ years of combined manufacturing experience
Workflow Software
- Automated data capture with a patient-centered approach enables operational consistency and helps minimize errors from manual contrast documentation.
*Bayer Sales Data based on active institution accounts through 2026.
†Bayer Sales Data based on number of vials sold 03/2011 through 02/2026.
‡Bayer Sales Data based on number of active service agreements as of 02/2026.
Broad Range of FDA-Approved Indications
Range of indications established through 8 Phase III clinical trials of 2,957 patients.
Safety profile established in clinical trials of 7,713 patients worldwide.
2011
CNS MRI Adult: Approval for central nervous system (CNS) magnetic resonance imaging (MRI) to detect and visualize areas with disrupted blood brain barrier and/or abnormal vascularity in adult and pediatric patients 2 years of age and older.
2014
CNS MRI Pediatric: Expanded CNS MRI indication to include pediatric patients less than 2 years of age, including term neonates.
2014
Breast MRI: Approval for MRI of the breast to assess the presence and extent of malignant breast disease in adult patients.
2016
MRA: Approval for magnetic resonance angiography (MRA) to evaluate known or suspected supra-aortic or renal artery disease in adult and pediatric patients, including term neonates.
2019
Cardiac MR: Approval for MRI to assess myocardial perfusion (stress, rest) and late gadolinium enhancement (LGE) in adult patients with known or suspected coronary artery disease (CAD).
The Power of the
Imaging Bulk Package (IBP)
An FDA-approved Imaging Bulk Package (IBP) presentation for multi-patient dosing with an FDA-cleared transfer spike in the MR suite
- Reduced Waste Compared to single-dose vials, the Imaging Bulk Package may enable more complete contrast usage
- Streamlined Workflow One multi-patient set up in the MR scan room eliminates the need to reach for several single-dose vials throughout the day
- Multi-patient Compliance The Gadavist Imaging Bulk Package is intended to be used only in a room designated for radiological procedures that involve intravascular administration of a contrast agent
View our IBP training videos for step-by-step guidance and walkthroughs.
We're Here When You Need Us. Connect Anytime.
Ordering Information
Gadavist can be ordered through all the same suppliers as for other Bayer imaging products.
To avoid additional shipping charges and to receive a 2% quick-pay discount when invoices are paid within 30 days, please establish an account with McKesson Specialty Distribution, the master distributor partner for Bayer Radiology:
- Call 1-877-259-4624 (option #1) or
- Contact your local distributor
If you have any questions about coding, coverage or reimbursement please contact the Bayer Reimbursement Hotline (managed through The Pinnacle Health Group) at 1-800-423-7539.
